Report cover image

Global Telmisartan Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Feb 07, 2025
Length 198 Pages
SKU # APRC20120914

Description

Summary

According to APO Research, The global Telmisartan market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Telmisartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Telmisartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Telmisartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Telmisartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Telmisartan include Beijing Wansheng Pharmaceutical, Boehringer Ingelheim, Hema Pharmaceuticals Pvt, Nippon Boehringer Ingelheim, Reddy's Laboratories (UK), Astellas Pharma Inc, Bayer, GSK and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Telmisartan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Telmisartan, also provides the sales of main regions and countries. Of the upcoming market potential for Telmisartan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Telmisartan sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Telmisartan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Telmisartan sales, projected growth trends, production technology, application and end-user industry.

Telmisartan Segment by Company

Beijing Wansheng Pharmaceutical
Boehringer Ingelheim
Hema Pharmaceuticals Pvt
Nippon Boehringer Ingelheim
Reddy's Laboratories (UK)
Astellas Pharma Inc
Bayer
GSK
Pfizer
Mylan
Novartis
Teva
Takeda
Abbott

Telmisartan Segment by Type

Injection
Freeze-Dried Powder

Telmisartan Segment by Application

Hospital
Clinic
Others

Telmisartan Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telmisartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Telmisartan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telmisartan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Telmisartan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Telmisartan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Telmisartan sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Telmisartan Market by Type
1.2.1 Global Telmisartan Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Market by Application
1.3.1 Global Telmisartan Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Telmisartan Market Dynamics
2.1 Telmisartan Industry Trends
2.2 Telmisartan Industry Drivers
2.3 Telmisartan Industry Opportunities and Challenges
2.4 Telmisartan Industry Restraints
3 Global Market Growth Prospects
3.1 Global Telmisartan Revenue Estimates and Forecasts (2020-2031)
3.2 Global Telmisartan Revenue by Region
3.2.1 Global Telmisartan Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Telmisartan Revenue by Region (2020-2025)
3.2.3 Global Telmisartan Revenue by Region (2026-2031)
3.2.4 Global Telmisartan Revenue Market Share by Region (2020-2031)
3.3 Global Telmisartan Sales Estimates and Forecasts 2020-2031
3.4 Global Telmisartan Sales by Region
3.4.1 Global Telmisartan Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Telmisartan Sales by Region (2020-2025)
3.4.3 Global Telmisartan Sales by Region (2026-2031)
3.4.4 Global Telmisartan Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Telmisartan Revenue by Manufacturers
4.1.1 Global Telmisartan Revenue by Manufacturers (2020-2025)
4.1.2 Global Telmisartan Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Telmisartan Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Telmisartan Sales by Manufacturers
4.2.1 Global Telmisartan Sales by Manufacturers (2020-2025)
4.2.2 Global Telmisartan Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Telmisartan Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Telmisartan Sales Price by Manufacturers (2020-2025)
4.4 Global Telmisartan Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Telmisartan Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Telmisartan Manufacturers, Product Type & Application
4.7 Global Telmisartan Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Telmisartan Market CR5 and HHI
4.8.2 2024 Telmisartan Tier 1, Tier 2, and Tier 3
5 Telmisartan Market by Type
5.1 Global Telmisartan Revenue by Type
5.1.1 Global Telmisartan Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Telmisartan Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Telmisartan Revenue Market Share by Type (2020-2031)
5.2 Global Telmisartan Sales by Type
5.2.1 Global Telmisartan Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Telmisartan Sales by Type (2020-2031) & (Tons)
5.2.3 Global Telmisartan Sales Market Share by Type (2020-2031)
5.3 Global Telmisartan Price by Type
6 Telmisartan Market by Application
6.1 Global Telmisartan Revenue by Application
6.1.1 Global Telmisartan Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Telmisartan Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Telmisartan Revenue Market Share by Application (2020-2031)
6.2 Global Telmisartan Sales by Application
6.2.1 Global Telmisartan Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Telmisartan Sales by Application (2020-2031) & (Tons)
6.2.3 Global Telmisartan Sales Market Share by Application (2020-2031)
6.3 Global Telmisartan Price by Application
7 Company Profiles
7.1 Beijing Wansheng Pharmaceutical
7.1.1 Beijing Wansheng Pharmaceutical Comapny Information
7.1.2 Beijing Wansheng Pharmaceutical Business Overview
7.1.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolio
7.1.5 Beijing Wansheng Pharmaceutical Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Comapny Information
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Boehringer Ingelheim Telmisartan Product Portfolio
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Hema Pharmaceuticals Pvt
7.3.1 Hema Pharmaceuticals Pvt Comapny Information
7.3.2 Hema Pharmaceuticals Pvt Business Overview
7.3.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hema Pharmaceuticals Pvt Telmisartan Product Portfolio
7.3.5 Hema Pharmaceuticals Pvt Recent Developments
7.4 Nippon Boehringer Ingelheim
7.4.1 Nippon Boehringer Ingelheim Comapny Information
7.4.2 Nippon Boehringer Ingelheim Business Overview
7.4.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Nippon Boehringer Ingelheim Telmisartan Product Portfolio
7.4.5 Nippon Boehringer Ingelheim Recent Developments
7.5 Reddy's Laboratories (UK)
7.5.1 Reddy's Laboratories (UK) Comapny Information
7.5.2 Reddy's Laboratories (UK) Business Overview
7.5.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Reddy's Laboratories (UK) Telmisartan Product Portfolio
7.5.5 Reddy's Laboratories (UK) Recent Developments
7.6 Astellas Pharma Inc
7.6.1 Astellas Pharma Inc Comapny Information
7.6.2 Astellas Pharma Inc Business Overview
7.6.3 Astellas Pharma Inc Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Astellas Pharma Inc Telmisartan Product Portfolio
7.6.5 Astellas Pharma Inc Recent Developments
7.7 Bayer
7.7.1 Bayer Comapny Information
7.7.2 Bayer Business Overview
7.7.3 Bayer Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bayer Telmisartan Product Portfolio
7.7.5 Bayer Recent Developments
7.8 GSK
7.8.1 GSK Comapny Information
7.8.2 GSK Business Overview
7.8.3 GSK Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 GSK Telmisartan Product Portfolio
7.8.5 GSK Recent Developments
7.9 Pfizer
7.9.1 Pfizer Comapny Information
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Pfizer Telmisartan Product Portfolio
7.9.5 Pfizer Recent Developments
7.10 Mylan
7.10.1 Mylan Comapny Information
7.10.2 Mylan Business Overview
7.10.3 Mylan Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Mylan Telmisartan Product Portfolio
7.10.5 Mylan Recent Developments
7.11 Novartis
7.11.1 Novartis Comapny Information
7.11.2 Novartis Business Overview
7.11.3 Novartis Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Novartis Telmisartan Product Portfolio
7.11.5 Novartis Recent Developments
7.12 Teva
7.12.1 Teva Comapny Information
7.12.2 Teva Business Overview
7.12.3 Teva Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Teva Telmisartan Product Portfolio
7.12.5 Teva Recent Developments
7.13 Takeda
7.13.1 Takeda Comapny Information
7.13.2 Takeda Business Overview
7.13.3 Takeda Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Takeda Telmisartan Product Portfolio
7.13.5 Takeda Recent Developments
7.14 Abbott
7.14.1 Abbott Comapny Information
7.14.2 Abbott Business Overview
7.14.3 Abbott Telmisartan Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Abbott Telmisartan Product Portfolio
7.14.5 Abbott Recent Developments
8 North America
8.1 North America Telmisartan Market Size by Type
8.1.1 North America Telmisartan Revenue by Type (2020-2031)
8.1.2 North America Telmisartan Sales by Type (2020-2031)
8.1.3 North America Telmisartan Price by Type (2020-2031)
8.2 North America Telmisartan Market Size by Application
8.2.1 North America Telmisartan Revenue by Application (2020-2031)
8.2.2 North America Telmisartan Sales by Application (2020-2031)
8.2.3 North America Telmisartan Price by Application (2020-2031)
8.3 North America Telmisartan Market Size by Country
8.3.1 North America Telmisartan Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Telmisartan Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Telmisartan Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Telmisartan Market Size by Type
9.1.1 Europe Telmisartan Revenue by Type (2020-2031)
9.1.2 Europe Telmisartan Sales by Type (2020-2031)
9.1.3 Europe Telmisartan Price by Type (2020-2031)
9.2 Europe Telmisartan Market Size by Application
9.2.1 Europe Telmisartan Revenue by Application (2020-2031)
9.2.2 Europe Telmisartan Sales by Application (2020-2031)
9.2.3 Europe Telmisartan Price by Application (2020-2031)
9.3 Europe Telmisartan Market Size by Country
9.3.1 Europe Telmisartan Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Telmisartan Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Telmisartan Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Telmisartan Market Size by Type
10.1.1 China Telmisartan Revenue by Type (2020-2031)
10.1.2 China Telmisartan Sales by Type (2020-2031)
10.1.3 China Telmisartan Price by Type (2020-2031)
10.2 China Telmisartan Market Size by Application
10.2.1 China Telmisartan Revenue by Application (2020-2031)
10.2.2 China Telmisartan Sales by Application (2020-2031)
10.2.3 China Telmisartan Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Telmisartan Market Size by Type
11.1.1 Asia Telmisartan Revenue by Type (2020-2031)
11.1.2 Asia Telmisartan Sales by Type (2020-2031)
11.1.3 Asia Telmisartan Price by Type (2020-2031)
11.2 Asia Telmisartan Market Size by Application
11.2.1 Asia Telmisartan Revenue by Application (2020-2031)
11.2.2 Asia Telmisartan Sales by Application (2020-2031)
11.2.3 Asia Telmisartan Price by Application (2020-2031)
11.3 Asia Telmisartan Market Size by Country
11.3.1 Asia Telmisartan Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Telmisartan Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Telmisartan Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Telmisartan Market Size by Type
12.1.1 SAMEA Telmisartan Revenue by Type (2020-2031)
12.1.2 SAMEA Telmisartan Sales by Type (2020-2031)
12.1.3 SAMEA Telmisartan Price by Type (2020-2031)
12.2 SAMEA Telmisartan Market Size by Application
12.2.1 SAMEA Telmisartan Revenue by Application (2020-2031)
12.2.2 SAMEA Telmisartan Sales by Application (2020-2031)
12.2.3 SAMEA Telmisartan Price by Application (2020-2031)
12.3 SAMEA Telmisartan Market Size by Country
12.3.1 SAMEA Telmisartan Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Telmisartan Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Telmisartan Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Telmisartan Value Chain Analysis
13.1.1 Telmisartan Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Telmisartan Production Mode & Process
13.2 Telmisartan Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Telmisartan Distributors
13.2.3 Telmisartan Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.